chartexchange

FDMT
4D Molecular Therapeutics, Inc. Common Stock
stockNASDAQ

At CloseNov 18, 2026 3:59:58 PM EST
10.47USD-2.966%(-0.32)679,720
After-hoursNov 18, 2026 4:26:30 PM EST
10.46USD-0.096%(-0.01)
Loading…
Loading…
589.73M
Healthcare
Biotechnology
HQ
EmeryVille, CA, USA
Previous Close
$10.79
Beta
1.91
52-Week High
$16.93 2026-08-19
52-Week Low
$6.96 2026-01-05
SMA 50
$12.91
SMA 200
$11.10
Avg. Vol 10D
955,818
Avg. Vol 30D
952,404
Avg. Vol 90D
944,014
Relative Vol
0.71
43.69M
10,897,478
0.3200%
20,715
FDMT Profile

the mission of 4d molecular therapeutics is to design and develop transformative gene therapy products using our proprietary technology to create novel adeno-associated virus variants to be utilized as treatments for serious unmet medical conditions. our products are unlocking the full potential of gene therapy to treat, and potentially cure, genetic diseases. a large number of patients and diseases, who previously were not treatable by gene therapy, will be addressable by 4d products. 4d has one of the deepest and most diverse product pipelines in the gene therapy field. adeno-associated virus (aav) vectors have emerged as a favored delivery vehicle for gene therapy in the human body. they can deliver the genes for therapeutic proteins to accessible tissues in the body and are generally considered safe. several aav gene therapy products are in late-stage clinical development, and one product is approved in the eu (glybera, uniqure). however, these first-generation aav vectors have lim

FDMT Performance
PeriodPriceDateChangeBeta
1W12.122026-11-12-13.66%4.168
1M12.292026-10-19-14.89%2.758
3M16.762026-08-19-37.59%2.298
6M8.412026-05-19+24.45%1.965
1Y10.802025-11-19-3.15%1.908
2Y8.672024-11-19+20.65%—
5Y23.062021-11-19-54.64%1.332
FDMT Stock Summary

4D Molecular Therapeutics, Inc. Common Stock (NASDAQ:FDMT) stock price today is $10.46, and today's volume is 679,720. FDMT is down 3.058% today. The 30 day average volume is 952,404. FDMT market cap is $589.73M with 56.38M shares outstanding.